- Home
- CDLX vs TVGN Comparison
CDLX vs TVGN Comparison
Compare CDLX & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLX
- TVGN
- Stock Information
- Founded
- CDLX 2008
- TVGN 2020
- Country
- CDLX United States
- TVGN United States
- Employees
- CDLX N/A
- TVGN N/A
- Industry
- CDLX Computer Software: Programming Data Processing
- TVGN Blank Checks
- Sector
- CDLX Technology
- TVGN Finance
- Exchange
- CDLX Nasdaq
- TVGN Nasdaq
- Market Cap
- CDLX 180.4M
- TVGN 174.4M
- IPO Year
- CDLX 2018
- TVGN N/A
- Fundamental
- Price
- CDLX $3.66
- TVGN $1.40
- Analyst Decision
- CDLX Hold
- TVGN
- Analyst Count
- CDLX 6
- TVGN 0
- Target Price
- CDLX $5.90
- TVGN N/A
- AVG Volume (30 Days)
- CDLX 969.0K
- TVGN 1.5M
- Earning Date
- CDLX 03-13-2025
- TVGN 02-20-2025
- Dividend Yield
- CDLX N/A
- TVGN N/A
- EPS Growth
- CDLX N/A
- TVGN N/A
- EPS
- CDLX N/A
- TVGN N/A
- Revenue
- CDLX $293,468,000.00
- TVGN N/A
- Revenue This Year
- CDLX N/A
- TVGN N/A
- Revenue Next Year
- CDLX $3.49
- TVGN N/A
- P/E Ratio
- CDLX N/A
- TVGN N/A
- Revenue Growth
- CDLX N/A
- TVGN N/A
- 52 Week Low
- CDLX $2.76
- TVGN $0.26
- 52 Week High
- CDLX $20.52
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- CDLX 49.79
- TVGN 56.82
- Support Level
- CDLX $2.76
- TVGN $1.24
- Resistance Level
- CDLX $3.53
- TVGN $1.57
- Average True Range (ATR)
- CDLX 0.25
- TVGN 0.16
- MACD
- CDLX 0.03
- TVGN 0.02
- Stochastic Oscillator
- CDLX 60.24
- TVGN 64.55
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.